DexamethasoneInsulin resistance and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1911卷 / 1期

关键词：

D O I：

10.1007/s40278-022-17470-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：173 / 173

相关论文

共 50 条

[21] AzithromycinCardiotoxicity and Off-label use: case report
Reactions Weekly, 2023, 1953 (1) : 100 - 100
[22] RituximabCellulitis and off-label use: case report
Reactions Weekly, 2022, 1911 (1) : 363 - 363
[23] MirtazapineOtotoxicity and off-label use: case report
Reactions Weekly, 2024, 2037 (1) : 255 - 255
[24] Cetuximab off-label useAcquired resistance: case report
Reactions Weekly, 2021, 1853 (1) : 123 - 123
[25] Multiple drugsDrug resistance, lack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1960 (1) : 300 - 300
[26] Multiple drugsLack of efficacy, drug resistance and off-label use: case report
Reactions Weekly, 2021, 1851 (1) : 242 - 242
[27] Erlotinib/osimertinib/selpercatinibAcquired resistance, diarrhoea and off-label use: case report
Reactions Weekly, 2021, 1871 (1) : 165 - 165
[28] Cefepime/piperacillin/tazobactamDevelopment of drug resistance and off-label use: case report
Reactions Weekly, 2023, 1943 (1) : 192 - 192
[29] Multiple drugsVancomycin resistance and thrombocytopenia following off-label use: case report
Reactions Weekly, 2023, 1958 (1) : 389 - 389
[30] Multiple drugsLack of efficacy, drug resistance and off-label use: case report
Reactions Weekly, 2023, 1961 (1) : 290 - 290

← 1 2 3 4 5 →